Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.  The report explores future marketing and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, ... Research Beam Model: Research Beam Product ID: 321834 0 USD New
2015-2019 European Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Spain, UK-Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2015-2019 European Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Spain, UK-Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

 
  • Category : Diagnostic and Biotech
  • Published On : August  2015
  • Pages : 630
 
 

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.


This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. 


The report explores future marketing and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.


Blood Group Genotyping


PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR,

Real Time PCR, Sanger DNA Sequencing, Pyrosequencing


Microarrays


BeadChip Array, BloodChip, Genome Lab SNP Stream,

Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS,

Mini-Sequencing


Blood Typing and Grouping Tests


ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,

Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),

Antiglobulin (Direct, C3 + IgG, IgG,  C3),

Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).


Infectious Disease Screening Tests


AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,

 Hepatitis (HAV NAT, HBV NAT, HBs Ag,  

Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT,

Syphilis, West Nile Virus NAT.


Sales and Market Share Analysis


Sales and market share estimates for leading

suppliers of blood typing, grouping and infectious disease screening tests

by country and individual product.


Geographic Regions


France, Germany, Italy, Spain, UK


Competitive Assessments


Strategic assessments of major suppliers and

emerging market entrants, including their sales, M&A,

product portfolios, marketing tactics, and new products in R&D.


Market Segmentation Analysis


- Comprehensive market segmentation

  analysis, including review of the market

  dynamics, trends, structure, size, growth,

  and key suppliers, by country.


- Test volume and sales forecasts for over 40 blood typing,

  grouping and infectious disease screening tests,

  including NAT, by country and market segment:


     - Blood Centers

     - Hospitals

     - Commercial/Private Laboratories


Current and Emerging Products


- Analysis of current and emerging molecular blood typing,

  grouping and infectious disease NAT screening assays.


- Review of automated and semi-automated

  molecular and immunohematology analyzers.


Technology Review


- Assessment of current and emerging

  technologies, and their potential applications

  for the blood banking market.


- Comprehensive lists of companies developing

  or marketing new technologies and products, by test.


Strategic Recommendations


- New product development opportunities

   for molecular blood typing, grouping and

   infectious disease NAT assays and instrumentation

   with significant market appeal.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.

                                                                             

Contains 630 pages and 152 tables